# TCR-Redirected T Cell Treatment in Patients With Recurrent HBV-related Hepatocellular Carcinoma Post Liver Transplantation

> **NCT04677088** · PHASE1 · UNKNOWN · sponsor: **Xiaoshun He** · enrollment: 7 (actual)

## Conditions studied

- Recurrent Hepatocellular Carcinoma

## Interventions

- **BIOLOGICAL:** TCR-T cells

## Key facts

- **NCT ID:** NCT04677088
- **Lead sponsor:** Xiaoshun He
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-29
- **Primary completion:** 2020-02-18
- **Final completion:** 2021-12
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2020-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04677088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04677088, "TCR-Redirected T Cell Treatment in Patients With Recurrent HBV-related Hepatocellular Carcinoma Post Liver Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04677088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*